参考文献/References:
[1] Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage[J]. Arterioscler Thromb Vasc Biol, 2005,25(10):2054-2061.
[2] Nair A, Kuban BD, Tuzcu EM, et al. Coronary plaque classification with intravascular radiofrequency data analysis[J]. Circulation,2002,106(17):2200-2206.
[3] Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque[J]. Heart,2004,90(12):1385-1391.
[4] Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP, et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis[J]. J Am Coll Cardiol, 2005,46(11):2038-2042.
[5] Stone GW, Maehara A, Lansky AJ, et al.A prospective natural-history study of coronary atherosclerosis[J]. N Engl J Med,2011,364(3):226-235.
[6] Yun KH, Mintz GS, Farhat N, et al. Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events(from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study)[J]. Am J Cardiol,2012,110(4):471-477.
[7] Dohi T, Mintz GS, McPherson JA, et al.Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study[J]. JACC Cardiovasc Imaging, 2013,6(8):908-916.
[8] Xie Y, Mintz GS, Yang J,et al. Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study[J]. JACC Cardiovasc Imaging,2014,7(4):397-405.
[9] Inaba S, Mintz GS, Farhat NZ,et al. Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT[J]. JACC Cardiovasc Imaging,2014,7(1):70-78.
[10] Noto T, Kameyama T, Satoh T,et al. Association between virtual histology intravascular ultrasound findings and subsequent coronary events in patients with acute coronary syndrome[J]. Int Heart J,2015,56(2):157-162.
[11] Sonneveld MA, Cheng JM, Oemrawsingh RM,et al. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study[J]. Thromb Haemost,2015,113(3):577-584.
[12] Battes LC, Akkerhuis KM, Cheng JM, et al. Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: results from the ATHEROREMO-IVUS study[J]. Int J Cardiol,2014,177(3):847-853.
[13] Cheng JM, Oemrawsingh RM,Garcia-Garcia HM,et al. Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris(from the ATHEROREMO-IVUS study)[J].Am J Cardiol,2014,114(10):1497-1503.
[14] Battes LC, Cheng JM, Oemrawsingh RM, et al.Circulating cytokines in relation to the extent and composition of coronary atherosclerosis: results from the ATHEROREMO-IVUS study[J]. Atherosclerosis, 2014,236(1):18-24.
[15] Cheng JM, Oemrawsingh RM, Akkerhuis KM, et al. Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome[J]. Biomarkers, 2014,19(7):611-619.
[16] Siqueira DA, Sousa AG, Costa Junior Jde R, et al. Correlation between plaque composition as assessed by virtual histology and C-reactive protein [J]. Arq Bras Cardiol,2013,101(1):78-86.
[17] Seo YH, Lee CS, Yuk HB,et al. Hypercholesterolemia and in-vivo coronary plaque composition in patients with coronary artery disease: a virtual histology-intravascular ultrasound study[J]. Korean Circ J, 2013,43(1):23-28.
[18] Wykrzykowska JJ, Mintz GS, Garcia-Garcia HM, et al. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes[J].JACC Cardiovasc Imaging,2012,5(3 Suppl):S10-18.
[19] Hong YJ, Jeong MH, Choi YH, et al. Positive remodeling is associated with vulnerable coronary plaque components regardless of clinical presentation: virtual histology-intravascular ultrasound analysis[J]. Int J Cardiol,2013,167(3):871-876.
[20] Guo J, Maehara A, Mintz GS, et al. A virtual histology intravascular ultrasound analysis of coronary chronic total occlusions [J]. Catheter Cardiovasc Interv, 2013,81(3):464-470.
[21] Lee MG, Jeong MH, Kim DH, et al. Can metabolic syndrome predict the vulnerable plaque in patients with stable angina pectoris? Virtual histology-intravascular ultrasound analysis[J]. J Cardiol, 2012,59(3):266-274.
[22] Schoenenberger AW, Urbanek N, Toggweiler S, et al.Ultrasound-assessed non-culprit and culprit coronary vessels differ by age and gender[J]. World J Cardiol, 2013,5(3):42-48.
[23] Kang SJ, Mintz GS, Weisz G, et al. Age-related effects of smoking on coronary artery disease assessed by gray scale and virtual histology intravascular ultrasound[J].Am J Cardiol, 2015,115(8):1056-1062.
[24] Dhawan SS, Corban MT, Nanjundappa RA,et al.Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma[J].Atherosclerosis, 2012,223(2):384-388.
[25] Ohshima K, Ikeda S, Kadota H,et al.Impact of culprit plaque volume and composition on myocardial microcirculation following primary angioplasty in patients with ST-segment elevation myocardial infarction: virtual histology intravascular ultrasound analysis[J]. Int J Cardiol,2013,167(3):1000-1005.
[26] Ding S, Xu L, Yang F,et al.Association between tissue characteristics of coronary plaque and distal embolization after coronary intervention in acute coronary syndrome patients: insights from a meta-analysis of virtual histology-intravascular ultrasound studies[J]. PLoS One, 2014,9(11):e106583.
[27] Amano H, Wagatsuma K, Yamazaki J, et al.Virtual histology intravascular ultrasound analysis of attenuated plaque and ulcerated plaque detected by gray scale intravascular ultrasound and the relation between the plaque composition and slow flow/no reflow phenomenon during percutaneous coronary intervention[J]. J Interv Cardiol, 2013,26(3):295-301.
[28] Tian J, Gu X, Sun Y, et al. Effect of statin therapy on the progression of coronary atherosclerosis[J]. BMC Cardiovasc Disord, 2012,12:70.
[29] Yang HB, Zhao XY, Zhao YT, et al. Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound[J]. Zhonghua Yi Xue Za Zhi, 2012,92(22):1550-1502.
[30] Nozue T, Yamamoto S, Tohyama S,et al.Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound [J]. Heart Vessels, 2015,30(1):36-44.
[31] Taguchi I, Oda K, Yoneda S,et al. Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies[J]. Am J Cardiol, 2013,111(9):1246-1252.
[32] Christoph M, Herold J, Berg-Holldack A, et al. Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial[J]. Heart Vessels, 2015,30(3):286-295.
相似文献/References:
[1]申倩南,综述,刘俊,等.冠状动脉临界病变的评价及治疗[J].心血管病学进展,2016,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.025]
SHEN Qiannan,LIU Jun.Assessment and Therapy of Intermediate Coronary Lesions[J].Advances in Cardiovascular Diseases,2016,(5):192.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.025]
[2]刘强,杨小梅,韩乾国.冠状动脉钙化研究进展[J].心血管病学进展,2015,(5):651.[doi:10.3969/j.issn.1004-3934.2015.05.033]
LIU Qiang,YANG Xiaomei,HAN Qianguo.Progress in Clinical Application of Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2015,(5):651.[doi:10.3969/j.issn.1004-3934.2015.05.033]
[3]郭远林.急性冠状动脉综合征风险评估方法学进展[J].心血管病学进展,2015,(6):681.[doi:10.3969/j.issn.1004-3934.2015.06.007]
GUO Yuanlin,YAN Hongbin.Progress in Tools for Risk Assessment of Acute Coronary Syndromes[J].Advances in Cardiovascular Diseases,2015,(5):681.[doi:10.3969/j.issn.1004-3934.2015.06.007]
[4]魏恒争,木胡牙提.比伐卢定在急性冠状动脉综合征患者PCI中的应用进展[J].心血管病学进展,2015,(6):725.[doi:10.3969/j.issn.1004-3934.2015.06.017]
WEI Hengzheng,MUHU Yati.Advance in Research of Bivalirudin During Percutaneous Coronary Intervention
in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2015,(5):725.[doi:10.3969/j.issn.1004-3934.2015.06.017]
[5]丁晓彤 张欣 左海奇 孙雨萌 贾赫 刘宏伟 孙鑫 孙延明 王岚峰 王姝.应激性心肌病诊治进展[J].心血管病学进展,2019,(5):778.[doi:10.16806/j.cnki.issn.1004-3934. 2019.05.028]
DING Xiaotong,ZHANG Xin,ZUO Haiqi,et al.Diagnosis and Treatment of Takotsubo Sydrome[J].Advances in Cardiovascular Diseases,2019,(5):778.[doi:10.16806/j.cnki.issn.1004-3934. 2019.05.028]
[6]白斯特 潘建华 蔡梦珊 姜馨.白介素-1家族在急性冠状动脉综合征发生和发展过程中的机制及治疗现状进展[J].心血管病学进展,2022,(1):64.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.017]
BAI Site,PAN Jianhua,CAI Mengshan,et al.Mechanism and Treatment Status of Interleukin-1 Family in Occurrence and Development of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2022,(5):64.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.017]
[7]陈纪元 陆泓雨 贺子熠 韩江莉.冠心病合并慢性肾脏病患者P2Y12受体拮抗剂治疗进展[J].心血管病学进展,2022,(7):582.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
CHEN Jiyuan,LU Hongyu,HE Ziyi,et al.P2Y12 Antagonists for Patients with Chronic Kidney Diseases and Coronary Heart Diseases[J].Advances in Cardiovascular Diseases,2022,(5):582.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]